Avenir Award Program for Genetics or Epigenetics of Substance Use Disorders (DP1 Clinical Trial Optional)
Key Information
Due Date: September 25, 2025
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant
Match Required: No
Contact Info:
grantsinfo@nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
This award is tailored to support those who are in the early stages of their careers and may not have the preliminary data required for a more extensive R01 grant, yet propose research with a high potential impact. By successfully showing promise in their field, they indicate potential to become future leaders.
The National Institute on Drug Abuse (NIDA) has conceptualized two separate Avenir Award Programs. One program is specifically dedicated to HIV/AIDS research, and the other primarily focuses on genetics or epigenetics studies related to Substance Use Disorders.
Key Dates
Open Date: October 21, 2022
Application Due Date: September 25, 2025
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses